$43292124 $45017213 ...Current liabilities $4131912 $4524607...Long-term debt $- $-...Total shareholders' equity $38073212 $39405606...
Date:2/14/2008
$43,292,124 $45,017,213
Current liabilities $4,131,912 $4,524,607
Long-term debt $- $-
Total shareholders' equity $38,073,212 $39,405,606
'/>"/>SOURCE Escalon Medical Corp. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.2.
Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System3.
Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access4.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound5.
QMed, Inc. Reports July Medicare SNP Enrollments6.
Phlo Affiliate Reports Expanded Coverage to Oregon Border7.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results8.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 20079.
Carrington Reports Second Quarter 2007 Results10.
Avitar Reports Third Quarter Financial Results for Fiscal 200711.
Response Genetics Reports Second Quarter 2007 Financial Results